LC

Leela Chetry

Active Director Director DIN 07787203
DIN 07787203 First appointment May 2017 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2017
Shareholding value •••• Premium profile

About Leela Chetry

Data last updated:

Leela Chetry is a Director at Inox Pharma Private Limited (since 2017). The company operates in Trading. Inox Pharma Private Limited reported revenue of ₹9 Lakh (FY 2025).

DIN 07787203
Primary Designation Director
Industry Trading
First Appointment 23 May 2017
Oldest Company Age 21 yrs
Largest company Inox Pharma Private Limited · ₹9 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Inox Pharma Private Limited U24232AS2005PTC007867
Director23 May 20172005₹9 Lakh (FY 2025)Active

Board colleagues of Leela Chetry

NameDINCompanyDesignation
Ajay Kumar Thapalia01042862Inox Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Inox Pharma Private Limited
Premium access

Shareholding and investment profile for Leela Chetry

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Leela Chetry

Leela Chetry currently holds 1 directorship: Inox Pharma Private Limited (Director, since 23 May 2017, revenue ₹9 Lakh (FY 2025)).

Leela Chetry was first appointed on 23 May 2017 as Director at Inox Pharma Private Limited.

The current boards of Leela Chetry's companies include Ajay Kumar Thapalia (Inox Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available